+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Commercial Biotechnology Separation Systems Market by Method, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887847
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Commercial Biotechnology Separation Systems Market grew from USD 26.55 billion in 2023 to USD 29.65 billion in 2024. It is expected to continue growing at a CAGR of 12.14%, reaching USD 59.24 billion by 2030.

The scope of commercial biotechnology separation systems encompasses technologies and processes designed for the separation, purification, and analysis of biological products. These systems are crucial for biopharmaceuticals, food and beverage industries, and academic research, where refined separation techniques ensure product purity, yield, and cost-effectiveness. Biotechnology separation systems find applications in protein separation, cell culturing, chromatography, membrane filtration, and centrifugation. End-use industries primarily include pharmaceutical and biotechnology companies, food manufacturers, and laboratory and clinical research firms. Market growth in this sector is driven by the increasing demand for biopharmaceuticals and biologics, evolving regulatory environments focusing on product quality, and technological advancements in separation techniques. A rising trend towards personalized medicine, alongside the growing use of international quality standards, adds to the scope of biotechnology separation systems.

Potential opportunities in the market are likely to emerge from advancements in nanotechnology and microfluidics, leading to enhanced separation efficiencies and reduced operational costs. Technology integration, such as AI and machine learning, can help optimize separation processes and minimize errors. Companies can capitalize on these trends by investing in research and collaborating with tech firms to develop advanced technological solutions. However, the market faces challenges such as high initial investments, stringent regulatory requirements, and the complexity of biological samples that could impede its rapid growth. Further, the need for highly skilled personnel to operate advanced systems poses an operational challenge. Innovations are needed in areas such as automated separation technology, eco-friendly solvents, and efficient scaling up of laboratory procedures to industrial applications.

The market is dynamic and research-intensive, meaning that constant innovation and adaptation are necessary. Companies must focus on operational efficiency, regulatory compliance, and product development to remain competitive. Furthermore, fostering partnerships with research institutions and leveraging government grants can provide additional avenues for innovation and market penetration. By emphasizing these areas, businesses can not only keep pace with technological advancements but also shape the future landscape of the biotechnology separation systems market.

Understanding Market Dynamics in the Commercial Biotechnology Separation Systems Market

The Commercial Biotechnology Separation Systems Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing demand for personalized medicines and cell-based therapies
    • Rise in funding by the government for research and development
    • Expanding adoption of magnetic separators for commercial production of plastics and chemicals
  • Market Restraints
    • High cost associated with commercial biotechnology separation systems
  • Market Opportunities
    • Ongoing advancements in commercial biotechnology separation systems
    • Government provides financial assistance to SMEs to introduce novel technologies
  • Market Challenges
    • Problems regarding stringent regulation requirements for product quality

Exploring Porter’s Five Forces for the Commercial Biotechnology Separation Systems Market

Porter’s Five Forces framework further strengthens the insights of the Commercial Biotechnology Separation Systems Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Commercial Biotechnology Separation Systems Market

External macro-environmental factors deeply influence the performance of the Commercial Biotechnology Separation Systems Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Commercial Biotechnology Separation Systems Market

The Commercial Biotechnology Separation Systems Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Commercial Biotechnology Separation Systems Market

The Commercial Biotechnology Separation Systems Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Commercial Biotechnology Separation Systems Market

The Commercial Biotechnology Separation Systems Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Commercial Biotechnology Separation Systems Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, GE HealthCare Technologies Inc., GL Sciences Inc., Hitachi, Ltd., Illumina, Inc., JASCO International Co., Ltd., LECO Corporation, Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novasep Holding SAS, PerkinElmer Inc., QIAGEN N.V., Repligen Corporation, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Commercial Biotechnology Separation Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Method
    • Conventional Methods
      • Centrifugation
      • Chromatography
      • Electrophoresis
      • Flow cytometry
      • Membrane filtration
    • Modern Methods
      • Biochip
      • Lab-on-a-chip
      • Magnetic separation
      • Microarray
  • Application
    • Agriculture
    • Biopharmaceutical
    • Cosmetics & Personal Care
    • Food & Beverage
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for personalized medicines and cell-based therapies
5.1.1.2. Rise in funding by the government for research and development
5.1.1.3. Expanding adoption of magnetic separators for commercial production of plastics and chemicals
5.1.2. Restraints
5.1.2.1. High cost associated with commercial biotechnology separation systems
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in commercial biotechnology separation systems
5.1.3.2. Government provides financial assistance to SMEs to introduce novel technologies
5.1.4. Challenges
5.1.4.1. Problems regarding stringent regulation requirements for product quality
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Commercial Biotechnology Separation Systems Market, by Method
6.1. Introduction
6.2. Conventional Methods
6.2.1. Centrifugation
6.2.2. Chromatography
6.2.3. Electrophoresis
6.2.4. Flow cytometry
6.2.5. Membrane filtration
6.3. Modern Methods
6.3.1. Biochip
6.3.2. Lab-on-a-chip
6.3.3. Magnetic separation
6.3.4. Microarray
7. Commercial Biotechnology Separation Systems Market, by Application
7.1. Introduction
7.2. Agriculture
7.3. Biopharmaceutical
7.4. Cosmetics & Personal Care
7.5. Food & Beverage
8. Americas Commercial Biotechnology Separation Systems Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Commercial Biotechnology Separation Systems Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Commercial Biotechnology Separation Systems Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET RESEARCH PROCESS
FIGURE 2. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 7. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET DYNAMICS
TABLE 7. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY BIOCHIP, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY LAB-ON-A-CHIP, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 40. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 41. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 42. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 44. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 45. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 46. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 62. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 63. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 64. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 66. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 67. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 68. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 74. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 75. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 76. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 98. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 99. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 100. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 111. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 112. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 113. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 115. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 116. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 117. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 119. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 120. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 121. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 123. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 124. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 125. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 127. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 128. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 129. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 135. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 136. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 137. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 147. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 148. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 149. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 151. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 152. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 153. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 155. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 156. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 157. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 171. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 173. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 183. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 184. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 185. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Commercial Biotechnology Separation Systems Market, which are profiled in this report, include:
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • GE HealthCare Technologies Inc.
  • GL Sciences Inc.
  • Hitachi, Ltd.
  • Illumina, Inc.
  • JASCO International Co., Ltd.
  • LECO Corporation
  • Luminex Corporation by DiaSorin S.p.A.
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • Novasep Holding SAS
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Repligen Corporation
  • Sartorius AG
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Waters Corporation

Methodology

Loading
LOADING...

Table Information